Delivery Order SPE2DB24D2101-SPE2DB25FKNPZ
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $19,857.04 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with a firm fixed price contract type and ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $67,829.29 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,071.75 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Prolia 60 mg/ml syringes with a ceiling value of $42,639.34. This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The award was competitively awarded with no...
- AmerisourceBergen Drug Corp was awarded a $57,441.34 delivery order by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Prolia 60 mg/mL syringes. This firm fixed-price, non-set-aside contract is scheduled for completion by August 4, 2025, with fulfillment taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a purchase of pharmaceutical supplies supporting federal medical procurement needs, primarily for military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,459.35 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed price terms and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its corporate office...
- The Defense Logistics Agency awarded a $26,999.75 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prolia 60 mg/ml syringes. This firm fixed price contract is non-competitive with no set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,777.14 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is well-positioned to fulfill...
- The Defense Logistics Agency awarded a $39,328.20 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Prolia 60 mg/mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNPZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,245.76 to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, with an ultimate completion date of August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a specific supply order under AmerisourceBergen's broader federal pharmaceutical procurement relationship. This delivery order is issued as a child contract under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The IDC serves as a comprehensive vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. Through this contract structure, AmerisourceBergen serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, with the DLA planning to expand pharmaceutical prime vendor capabilities through multiple regional contracts in subsequent generations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 8/18/25 |